CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS (NYSE: CVS) opened a Workforce Innovation and Talent Center and Community Resource Center in Fort Worth on Oct. 7, 2025, in partnership with Fort Worth Housing Solutions.
The WITC offers no-cost, hands-on training for roles such as pharmacy technicians, customer service associates and call center representatives in a simulated retail environment, with graduates encouraged to apply to CVS. The CRC, supported by Aetna, will offer health education, benefits navigation, computers, teleconferencing and space for community events; health screenings are planned for late 2025.
CVS has invested $232 million+ in affordable housing across Texas, helped create or preserve nearly 14,000 housing units, invested in an 80-unit Babers Manor mixed-income residence, and awarded over $700,000 to local organizations this year.
Aetna (NYSE: CVS) has unveiled its 2026 Medicare Advantage (MA) plans, expanding access to affordable healthcare across 43 states plus Washington, D.C., reaching 57 million Medicare-eligible beneficiaries. The company will maintain $0 monthly premium plans in every service area, accessible to 82% of Medicare-eligible beneficiaries.
Key offerings include $0 copays for Tier 1 drugs, covered vaccines at in-network pharmacies, and essential preventive services. The company is expanding its Special Needs Plans, with Chronic Condition SNPs growing to 18 states and Dual Eligible SNPs expanding to 119 new counties. Members will benefit from a $2,100 annual out-of-pocket maximum for prescription drugs and access to comprehensive networks including major pharmacy chains.
CVS Health (NYSE: CVS) has scheduled its third quarter 2025 earnings conference call for Wednesday, October 29th, 2025, at 8:00 a.m. ET. During this call, the company will discuss its Q3 2025 financial performance with analysts and investors.
The event will be accessible through an audio webcast on the Investor Relations section of CVS Health's website at investors.cvshealth.com. The webcast recording will remain available for replay on the website for one year following the event.
Omnicare, a subsidiary of CVS Health (NYSE: CVS), has initiated voluntary Chapter 11 bankruptcy proceedings in response to litigation challenges and industry-wide financial pressures. The company has secured $110 million in debtor-in-possession financing to maintain operations during the restructuring process.
The bankruptcy filing follows a court ruling in the U.S. District Court for the Southern District of New York regarding alleged technical violations of pharmacy law. Omnicare plans to use this process to evaluate restructuring options, including a potential standalone restructuring or sale strategy. The company emphasizes that it will continue providing uninterrupted pharmacy services to long-term care facilities and maintain regular business operations, including employee wages and vendor payments.
CVS Health's Aetna (NYSE: CVS) announced the expansion of its Aetna Clinical Collaboration (ACC) program, which will be implemented in ten hospitals by the end of 2025. The program embeds Aetna nurses within hospital staff to support Medicare Advantage members during their hospital discharge and transition process.
The initiative, which has already shown promising results with 25% of program members actively engaged with an Aetna care manager, aims to reduce 30-day readmission rates and hospital length of stay by 5% year-over-year. The program is particularly significant as nearly 20% of Medicare-insured patients face hospital readmission within 30 days of discharge.
CVS Health (NYSE: CVS) has reopened its Pacific Palisades store at 864 Swarthmore Avenue, which was damaged during the January wildfires in California. The store is one of the first businesses to resume operations in the area, featuring an expanded pharmacy, improved consultation areas, and updated layout.
The renovated location has been tailored to serve current community needs, particularly focusing on construction workers and first responders, with an expanded selection of grab-and-go items. CVS Health has demonstrated its commitment to wildfire recovery efforts through $2 million in grants and product donations to affected California communities.
CVS Health (NYSE: CVS) has declared a quarterly dividend of $0.665 per share on its Common Stock. The dividend will be paid on November 3, 2025, to shareholders of record as of October 23, 2025. This regular dividend announcement demonstrates CVS Health's continued commitment to providing shareholder returns.
CVS Health (NYSE: CVS) Foundation has announced a $1 million grant distribution through its Hometown Fund to support 20 Rhode Island-based organizations. The initiative aims to improve healthcare accessibility and community health outcomes in areas surrounding CVS's corporate offices.
The grants will support various community services including nutritious food access, supportive housing, and educational resources. Since 2022, the CVS Health Foundation has invested $8 million in Greater Hartford and Rhode Island organizations. Notable recipients include Connecting for Children and Families, Adoption Rhode Island, and Amos House, among others.
This initiative complements CVS Health's broader community engagement efforts, including their Project Health initiative which screened over 1,300 Rhode Island participants last year, and a previous $1 million grant to Women & Infants Hospital for maternal health services.
CVS Health Foundation (NYSE: CVS) has announced a $1 million grant distribution through its Hometown Fund to support 20 organizations in the Greater Hartford area. The grants, focused on improving healthcare accessibility and community health outcomes, will support various services including nutritious food, supportive housing, and educational resources.
Malta House of Care, Inc. is among the key beneficiaries, receiving funds to provide free behavioral health care and community support. Since 2022, the Foundation has invested $8 million in Greater Hartford and Rhode Island organizations. Additionally, CVS Health has invested $2 million in creating a Hartford Health Zone and $16 million in affordable housing initiatives in the area.
CVS Health (NYSE: CVS) has announced the availability of updated 2025-2026 flu vaccines at CVS Pharmacy and MinuteClinic locations nationwide. A company survey reveals 63% of consumers plan to get flu shots this season, with 65% planning to get vaccinated before November.
The company is expanding its healthcare services by offering 3-in-1 combo testing for Influenza A, Influenza B, and COVID-19 in 38 states and D.C. In select states, pharmacists can both test and treat these conditions in a single visit. CVS is incentivizing vaccinations with a $10 off $20 purchase offer and $2 ExtraBucks Rewards for ExtraCare members receiving CDC-recommended vaccines.